Google Answers Logo
View Question
 
Q: symptoms HIV-2 ( No Answer,   3 Comments )
Question  
Subject: symptoms HIV-2
Category: Health > Conditions and Diseases
Asked by: daze-ga
List Price: $15.00
Posted: 13 Sep 2002 20:34 PDT
Expires: 11 Oct 2002 15:11 PDT
Question ID: 64876
How does the seronegative form of HIV-2 differ from the regular HIV-2?
 I know that the few carriers of it show that it is slower to
progress and it is weaker...but beyond the fact that  culture and
proviral HIV-2 DNA method has to be used to identify it,  I have not
found any information.  I am sure that someone has more than
that...Harvard AIDS project works with HIV-2 in W. Africa.
Answer  
There is no answer at this time.

The following answer was rejected by the asker (they received a refund for the question).
Subject: Re: symptoms HIV-2
Answered By: crabcakes-ga on 14 Sep 2002 00:23 PDT
Rated:1 out of 5 stars
 
daze-ga,

This was quite and interesting question! While there certainly is a
lot more data available about HIV-1, I found quite a bit about HIV-2
for you.( I will get to the seronegative issue towards the end of the
answer.)

Harvard researchers did indeed first report the presence of HIV-2 in
Africa, in 1985. The first case of HIV-2 in the United States appeared
1987, but there are no accurate statistics as testing fro HIV-2 is not
routine in the US. The presence of HIV-2 is more prevalent in Western
Africa, particularly Senegal, The Ivory Coast, Gambia, Guinea-Bissau,
Mali, Mauritania, Nigeria, and Sierra Leone. One out of every 100
people in these countries is infected with HIV-2.

 HIV-1 and HIV-2 share many genetic similarities. 
This Harvard site offers a very nice graphic of the HIV-1 and the
HIV-2 genome, displaying the similarities and the differences.
http://www.hsph.harvard.edu/hai/images/laboratories/figure_HIV1and2.jpg

 The rate of AIDS development from HIV-1 infection is over ten times
greater than the rate of developing AIDS from HIV-2. Some in vitro
studies suggest that HIV-2 may actually  provide immunity against
HIV-1 (A sore of vaccine effect). The development of antibodies is
similar in HIV-1 and HIV-2. Antibodies usually become detectable
within 3 months of infection.
http://www.hsph.harvard.edu/facres/knk.html

According to this Harvard site, researchers have found that infection
with HIV-2 reduced the chances of acquiring HIV1 infection by
approximately 70%, in a study in Senegal, West Africa.
  http://www.apin.harvard.edu/senegal.html  

According to the CDC, both  HIV-1 and HIV-2  have the same modes of
transmission. Full-blown AIDS seems to develop slower and be less
severe than people infected with HIV-1.
http://www.cdc.gov/hiv/pubs/facts/hiv2.htm

This report, from Aaron Diamond AIDS Research Center, Rockefeller
University, New York discusses how HIV-2 arrived from  cross-species
transmission from a simian form of the retrovirus found in sooty
magabeys.

http://www.ncbi.nlm.nih.gov/htbin-
post/Entrez/query?uid=97248444&form=6&db=m&Dopt=b

(Sooty magabeys—(such an odd sounding name!) are a simian species,
closely resembling a baboon). To learn about this species visit:
 http://brainmuseum.org/Specimens/primates/sooteymangabey/
Or 
http://www.szgdocent.org/pp/p-mangbey.htm


This Harvard site shows that infection with HIV-2,which is a far less
virulent form of the virus, protects against infection with HIV-1, a
finding with implications for vaccine development.
http://www.hsph.harvard.edu/press/releases/press032499.html

=================================
For more reading about HIV-2, visit these links:
http://www.cdc.gov/hiv/pubs/facts/hiv2.htm     An excellent
comprehensive explanation of  HIV-2, testing, and people at risk.

This site, from the University of North Carolina, describes their
testing for HIV-1 and HIV-2
http://www.pathology.med.unc.edu/path/labs/test/h/hiv_ab.htm

http://www.ccsf.edu/Departments/Biology/resist.htm

http://www.aegis.com/pubs/beta/1995/BE952634.html

http://glossary.hivatis.org/index.asp 
A glossary of HIV-2 terms. 

http://www.med.umich.edu/intmed/infectious/faculty/markovitz/markovitzresint.htm

http://hiv-web.lanl.gov/content/hiv-db/HelpDocs/subtypes-more.html#HIV-2

http://grants2.nih.gov/grants/guide/notice-files/not95-017.html

http://www.adarc.org/hiv/stages/index.htm
Graphic of how  HIV enters and infects a T-cell.

http://www.avert.org/hivtypes.htm

http://www.avert.org/aidsinafrica.htm
A page of interesting links to many sources of information about
Aids/HIV in Africa.

http://www.avert.org/testing.htm
Excellent explanation of testing.

http://www.avert.org/origins.htm

====================================
Finally, 
In your question, you ask “How does the seronegative form of HIV-2
differ from the regular HIV-2?”. If a person is seronegative, it
indicates one of two possibilities. The person is free of the HIV-2
virus, OR, the person has been so recently infected that they have not
yet developed a sufficient  HIV-2 antibody titer to test positive. (
It can take up to three months for antibodies to be detected, using
serological testing)
Dr. Phyllia Kanki, Professor of Immunology and Infectious Diseases
Department of Immunology and Infectious Diseases , Harvard writes
“HIV-2 proviral load is similar to that of HIV-1 but plasma viral
titers are at least 30 fold lower suggesting quiescent infection.
Further studies seek to identify the viral or host factors critical
for virus containment.” Dr. Kanki’s laboratory developed a viral load
test for the presence of HIV-1 and HIV-2.
http://www.hsph.harvard.edu/facres/knk.html

“Viral load testing measures the number of copies of viral RNA per one
milliliter of blood.  Viral loads for HIV-infected people can range
from undetectable to more than a million copies per ml. The tests are
not sensitive enough yet to detect viral loads lower than about 25
copies per ml. So even though an undetectable viral load is a very
good sign, it does not necessarily mean that the person is
HIV-negative. It just means that there is not enough virus to be
detected. “
http://www.hivchannel.com/routinetesting/index.shtml#vir


More about viral load testing:
http://www.thebody.com/Forums/AIDS/Labs/Current/Q141448.html



========================================
Symptoms of HIV-2 are similar to HIV-1:
The following may be warning signs of infection with HIV: 
·       rapid weight loss 
·	dry cough 
·	recurring fever or profuse night sweats 
·	profound and unexplained fatigue 
·	swollen lymph glands in the armpits, groin, or neck 
·	diarrhea that lasts for more than a week 
·	white spots or unusual blemishes on the tongue, in the mouth, or in
the throat
·	pneumonia 
·	red, brown, pink, or purplish blotches on or under the skin or
inside the mouth, nose, or eyelids
·	memory loss, depression, and other neurological disorders 
http://www.cdc.gov/hiv/pubs/faq/faq5.htm
=========================================

Hopefully this answer will provide you with the information you seek.
If this answer does not provide what you were searching for, please
ask for a clarification.

-Regards,
crabcakes

search strategy:
HIV-2
Viral load testing
Harvard + HIV-2
symptoms + HIV-2

Request for Answer Clarification by daze-ga on 14 Sep 2002 12:28 PDT
Hi,  my question asks only about the seronegative FORM of HIV-2,, not
seronegative status, and not for the information you provided,   The
seronegative form is a type of HIV-2, as I undersatnd it that has
recently been identified in India.  It has been found in a few
people,, known as carriers.... They have been tested well beyond the
time frame usually used,, 3 or 6 months.  see Intl J STD AIDS 2000
Jan;11(1):31-7.  What is the clincial appearance of this variant? what
is known about this variant?  How is it like HIV-2?  How is it
different?  For how long have the carriers been followed?  Where is
the best information on this variant? Harvard?  elsewhere?  Pease try
again.

Clarification of Answer by crabcakes-ga on 14 Sep 2002 19:30 PDT
daze,
I am sorry you were unhappy with my answer. I included extra
information partly because your subject line read “ Symptoms  HIV-2”.
I incorrectly assumed you were interested in knowing HIV-2 symptoms as
well. The other extra material I presented, was simply that, extra
information, in case you cared to read furthur.

When you say “ seronegative form of HIV-2”, I must assume you mean
people who have been infected with the HIV-2 virus, but still test
negative (seronegative).  I have found no form or subtype of HIV, 
that uses  “seronegative form of HIV-2” as a naming convention.

I believe this site will answer many of your questions, regarding
similarities of the HIV types, origin, and epidemiology.
http://www.socgenmicrobiol.org.uk/JGVDirect/18253/18253ft.htm

“Some people are rapid progressors who develop AIDS in only a few
years following infection. Slow progressors remain asymptomatic for
over a decade following infection. A very small number of people are
nonprogressors, resistant to either HIV infection or progression to
AIDS. The best studied resistance mechanism is lack of the CCR5
chemokine receptor required for HIV to infect macrophages. This
mutation was discovered in people who were repeatedly exposed to HIV
but showed no sign of infection or seroconversion. People homozygous
for the CCR5 mutation (found in 1% of Caucasians but not in Japanese
or West African subjects) were nearly completely protected from
infection. (Interestingly, their immune responses were normal in spite
of the absence of CCR5, illustrating the redundant nature of chemokine
action). The few homozygotes who were infected are believed to have
been infected by the CXCR4-tropic form of the virus. Heterozygotes for
the CCR5 co-receptor showed a slower progression to AIDS. Other
populations of long term nonprogressors who are HIV-positive (have
antibodies to HIV) and of highly exposed but seronegative people who
have HIV-specific CTL and Th1 cells are being studied.” Located below
the middle of the page, this quote is from an immunology study module
of the University of Arizona, located here:
http://microvet.arizona.edu/Courses/MIC419/SystemModules/microbeevasion.html

An article in the Deccan Herald briefly discusses HIV which includes
subtype-C, which is found in India.
http://www.deccanherald.com/deccanherald/july16/snt2.htm
Several sub-types of HIV in India and Pakistan  are discussed here
://www.google.com/search?q=cache:qn2Ycof_OqkC:www.pbrc.hawaii.edu/rcmi/symposium/docs/sample-abstract.doc+HIV+subtype-c+%2B+India&hl=en&ie=UTF-8
Discussing the gene sequencing of HIV variants in India, from Reuters:
http://www.aegis.com/news/re/1999/RE990103.html

From Harvard, about the early discovery of HIV-2 in India.
http://www.hsph.harvard.edu/hai/conferences_events/2001/vaccine_development/1998b/vacdev-10.html

From an article on the BBC website:
“Very few cases of HIV-2 infection occur outside Western Africa,
because the transmission of the virus is less efficient. The genome of
HIV-1 and HIV-2 are only partially homologous10. For that reason,
HIV-2 is not necessarily detected by conventional laboratory tests
which detect the HIV-1 antibody. The HIV-2 infection takes longer to
develop to AIDS. The course of the syndrome is less aggressive because
HIV-2 has a lower impact on the immune system (compared to HIV-1)
until late in the course of AIDS. The mortality rate from HIV-2
infection is only two-thirds that for HIV-1.” “HIV-1 is the
predominant type worldwide, and it is more aggressive than HIV-2
(HIV-2 is endemic in Western Africa). HIV-1 is further subdivided into
three groups of subtypes, mutants, namely M (major), O (outlier) and N
(because it is between M and O). HIV-1-M subtypes (A through H) vary
slightly. The geographical distribution of these subtypes is
inhomogenous.”
http://www.bbc.co.uk/dna/h2g2/A744770


From the CDC:
“The first pattern consists of a restricted number of HIV-1 viral
subtypes or their combination with HIV-2. Examples include HIV-1
subtypes E and B in Thailand (5) and HIV-1 subtype C and HIV-2 in
India “
http://www.cdc.gov/ncidod/eid/vol4no4/pieniaze.htm


A study at McGill University did a study of 28 individuals who were
exposed to the HIV virus. “Eighteen individuals were persistently
seronegative (group 1) while ten seroconverted within three months of
study entry.”
http://www.iavi.org/reports/280/aidsvax2001.htm
The Aaron Diamond AIDS Research Center studied HIV-exposed
seronegative men and the  protective  effects of chemokines.
 http://www.cdc.gov/ncidod/eid/vol3no3/smith.htm


In this site, which  I included  above, in the first part of my
answer, mention is made  that there were 2 patients in India with
HIV-2 (No sero-reactivity type given)
http://www.cdc.gov/hiv/pubs/facts/hiv2.htm

Prevalence of HIV-2 in India
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12170934&dopt=Abstract

An article that touches on testing differences of HIV-1 and HIV-2
http://www.fda.gov/ohrms/dockets/ac/00/backgrd/3620b1u.pdf

Tracking the HIV virus:
http://www.aidsinfonyc.org/hivplus/issue7/report/evolution.html

I was unable to find further information beyond the information you
already had, the previous information I supplied you with, and the
newest information. If you are not satisfied with this answer, feel
free to request a refund.

Regards,
crabcakes
Reason this answer was rejected by daze-ga:
My question was not answered.  Either the researcher did not read, or
did not understand my question.  In the responses to his/her
information I referenced a journal article describing this new form of
HIV-2.  If the researcher hd gone to the  article referenced, there
could be now way my questionn could be misunderstood.  The article
concerns a group of carriers in India...people who are infected with
HIV-2, but who have such a low level of the virus that they test
negative by serological methods.  Using culture and proviral DNA
methods, they test positive.  I came to google for help becausse all I
could find  was tehe one article I referencned.   the  researcher did
nothing for me, and given my responses, which were specific regaarding
what I needed, to include the journal article I startd with, I can
only conclude that he/she knowingly sent a volume of readily available
info. on standard HIV-2, esp. those who have it but don't get the
usual HIV illnesses... With my response notes, ther is no way that my
meaning could have been misunderstood.     My time should not hvae
been wsted.. I should have been told  after my first response that an
answere would not be forth coming.
daze-ga rated this answer:1 out of 5 stars
even with a journal article reference as a lead, the researcher did
not tell me anything about the "carriers" of a very low level, slow to
replicate , HIV-2 type, or variant.......most of what was sent was
compiled because he/she went by the title of my request....rather than
read the text and answer th e question...  I did not caitalize or
italicize ......seronegative form.....  it is too new to have a name,,
so i used the term as it is used in the journal article I quoted.  I
want a refund.

Comments  
Subject: Re: symptoms HIV-2
From: debbi-ga on 15 Sep 2002 02:33 PDT
 
Are you talking about long-term non-progressive HIV patients?
Subject: Re: symptoms HIV-2
From: daze-ga on 15 Sep 2002 17:33 PDT
 
No, I am not.  read my response. then look up the journal article that
I reference.  ....here is the journal ,,, name,, date,,  page,,,etc. "
Int J STD AIDS  2000 Januray 11(1) :31-7.  The article describes a
weak  form of HIV-2 that has been found in some people who test
negative for HIV-2 when the standard serological test is used.   The
virus is in a weak state that can only be found by use of a "culture
and proviral HIV-2 DNA" method. I have only seen the  abstract of the
article..   IMHO  you should get the entire article and accompanying
references....as yo u look for information about  how the weak
"seronegative"  form differs from standard HIV-1 and HIV-2.  This is
new...do not send any more information unless it addresses my
question. I di not ask for any of  what has been sent so far.
Subject: Re: symptoms HIV-2
From: daze-ga on 15 Sep 2002 17:41 PDT
 
read the journal article......the abstract seems to describe a weak
form of HIV-2.  then please answer my questions...posed in this same
letter.  look up the journal   article I list...If  you do not want to
search for this variant,,, just say so and research someone else...I
don't have time  to waste.

Important Disclaimer: Answers and comments provided on Google Answers are general information, and are not intended to substitute for informed professional medical, psychiatric, psychological, tax, legal, investment, accounting, or other professional advice. Google does not endorse, and expressly disclaims liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in answers or comments. Please read carefully the Google Answers Terms of Service.

If you feel that you have found inappropriate content, please let us know by emailing us at answers-support@google.com with the question ID listed above. Thank you.
Search Google Answers for
Google Answers  


Google Home - Answers FAQ - Terms of Service - Privacy Policy